Risk factors for diabetes insipidus in Langerhans cell histiocytosis

Pediatric Blood and Cancer

Volumn 46, Issue 2, 2006, Pages 228-233

  Crois, Nicole ^a,h   Potschger U ^a   Prosch, H ^a   Minkov, M ^a   Arico, M ^b   Braier, J ^c   Henter, J I ^d   Janka Schaub, G ^e   Ladisch, S ^f   Ritter, J ^g   Steiner, M ^a   Unger, E ^a   Gadner, H ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b Ospedale dei Bambini G Di Cristina   (Italy)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Central nervous system; Diabetes insipidus; Langerhans cell histiocytosis; Magnetic resonance imaging; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; MEPREDNISONE; MERCAPTOPURINE; PREDNISONE; STEROID; VINBLASTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CHILD; DIABETES INSIPIDUS; DISEASE ACTIVITY; DISEASE COURSE; HISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RISK; TREATMENT OUTCOME;

CLINICAL TRIALS; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 30444457707     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20425     Document Type: Article

References (26)

1. Avery ME, Mcaffee JG, Giuld JG. The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schuller-Christian disease and Letterer Siwe disease): A study of 40 cases. Am J Med 1957;22:636-652.
2. Sims DG. Histiocytosis X; follow-up of 43 cases. Arch Dis Child 1977;52:433-440.
3. Ceci A, De Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: Results from the Italian Cooperative AIEOP-CNR-H.X '83 study. Med Pediatr Oncol 1993;21:259-264.
4. Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans' cell histiocytosis: 25- year experience at the University of California, San Francisco. J Clin Oncol 1996;14:2073-2082.
5. The French Langerhans' Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.
6. Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocytosis: Retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377-385.
7. Donadieu J, Rolon MA, Thomas C, et al. Endocrine involvement in pediatric-onset langerhans' cell histiocytosis: A population-based study. J Pediatr 2004;144:344-350.
8. Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004;42:438-444.
9. Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med 1989;321:1157-1162.
10. Grois N, Flucher-Wolfram B, Heitger A, et al. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248-256.
11. Broadbent V, Pritchard J. Diabetes insipidus associated with Langerhans cell histiocytosis: Is it reversible? Med Pediatr Oncol 1997;28:289-293.
12. Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans' cell histiocytosis: Is radiation therapy indicated? Med Pediatr Oncol 1997;29:36-40.
13. Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: Clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000;85:1370-1376.
14. Minehan KJ, Chen MG, Zimmerman D, et al. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. Int J Radiat Oncol Biol Phys 1992;23:519-524.
15. Ottaviano F, Finlay JL. Diabetes insipidus and Langerhans cell histiocytosis: A case report of reversibility with 2-chlorodeoxyadenosine. J Pediatr Hematol Oncol 2003;25:575-577.
16. Grois N, Prayer D, Prosch H, et al. Course of diabetes insipidus in Langerhans cell histiocytosis and clinical impact of associated magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatric Blood and Cancer 2004;43:59-65.
17. Nanduri VR, Bareille P, Pritchard J, et al. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 2000;53:509-515.
18. Donadieu J, Rolon MA, Pion I, et al. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: Efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 2004;89:604-609.
19. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994;23:72-80.
20. Prayer D, Grois N, Prosch H, et al. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 2004;25:880-891.
21. Ladisch S, Gadner H, Arico M, et al. LCH-I: A randomized trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Med Pediatr Oncol 1994;23:107-110.
22. LCH Study Group of the Histiocyte Society. LCH II - Treatment Protocol of the Second International Study for Langerhans Cell Histiocytosis. Protocol 1996.
23. LCH Study Group of the Histiocyte Society. LCH III - Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis. Protocol 2001.
24. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-1235.
25. Calming U, Bemstrand C, Mosskin M, et al. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. J Pediatr 2002;141:435-440.
26. Berry DH, Gresik MV, Humphrey GB, et al. Natural, history of histiocytosis X: A Pediatric Oncology Group Study. Med Pediatr Oncol 1986;14:1-5.